Columbia researchers found that exposure to famine early in gestation—but not in the first years of life or late gestation—increased the risk of developing type 2 diabetes decades later.
A new BRAIN Initiative atlas showcases the diverse cell populations within the human hypothalamus, paving the way to discovering novel cellular targets for obesity and metabolic disease
Studies exploring metformin’s power to prevent prostate cancer progression have been inconclusive. Columbia research now shows that the drug has promise, but only for specific patients.
2017 Naomi Berrie Award winner Bradford B. Lowell, MD, PhD, is an innovator in creating cutting-edge genetic engineering and neuroscience techniques to study energy balance and obesity.
Michael Rosenbaum, MD, director of the new FIT clinic at Columbia for treatment of pediatric obesity, explains his research on weight loss and metabolism.
Glucoracle is a new app for people with type 2 diabetes that uses a personalized algorithm to predict the impact of particular foods on blood sugar levels.
The Naomi Berrie Diabetes Center has launched an initiative to study the relationship between the brain and metabolic disorders such as obesity and diabetes.